Satsuma Pharmaceuticals, Inc. SC 13D and SC 13D/A reports

Location
4819 Emperor Boulevard, Suite 340, Durham, NC
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
7/19/2024, 10:41 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Jun 12, 2023
SC 13D/A Report SC 13D/A Jun 8, 2023
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D/A(#2E) May 2, 2023
SC 13D/A Report SC 13D/A Apr 18, 2023
SC 13D/A Report SC 13D/A Apr 17, 2023
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D/A(#1) Jan 27, 2023
SC 13D Report SCHEDULE 13D Mar 31, 2021
SC 13D Report GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D Mar 15, 2021
SC 13D/A Report SC 13D/A Mar 2, 2021
SC 13D Report SCHEDULE 13D Sep 17, 2019